XLIMus drug eluting stent: A randomIzed controlled Trial to assess endothelialization. The XLIMIT trial

BACKGROUND: Thin strut 3rd generation drug eluting stents offer the potential advantage over the previous generation of better technical performance and reduced neointimal proliferation parameters, which are linked to mid and late term device failure. AIM: To evaluate the performance of the Xlimus s...

Descripción completa

Detalles Bibliográficos
Autores principales: Testa, Luca, Pero, Gaetano, Bollati, Mario, Casenghi, Matteo, Popolo Rubbio, Antonio, Cuman, Magdalena, Moreno, Raul, Serra, Antoni, Gomez, Joan Antoni, Bedogni, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487315/
https://www.ncbi.nlm.nih.gov/pubmed/31061876
http://dx.doi.org/10.1016/j.ijcha.2019.100363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487315/
https://www.ncbi.nlm.nih.gov/pubmed/31061876
http://dx.doi.org/10.1016/j.ijcha.2019.100363

Ejemplares similares